Headlands Technologies LLC Acadia Pharmaceuticals Inc Transaction History

Headlands Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$16.61 - $20.29 $579,954 - $708,445	-34,916 Reduced 72.35%	13,341 $221,000
Q4 2024 Feb 12, 2025	BUY	$14.29 - $18.76 $51,715 - $67,892	3,619 Added 8.11%	48,257 $885,000
Q3 2024 Nov 12, 2024	SELL	$15.14 - $19.14 $190,324 - $240,608	-12,571 Reduced 21.97%	44,638 $686,000
Q2 2024 Aug 07, 2024	BUY	$14.62 - $18.42 $798,368 - $1.01 Million	54,608 Added 2099.5%	57,209 $929,000
Q1 2024 May 07, 2024	BUY	$17.79 - $30.86 $46,271 - $80,266	2,601 New	2,601 $48,000

Q2 2023 Aug 03, 2023	BUY	$17.8 - $25.65 $99,003 - $142,665	5,562 New	5,562 $133,000

373

162M

1.46M

1.09M

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.89B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Headlands Technologies LLC with notifications on news.